Karolinska Development AB (publ): Karolinska Development's portfolio company Umecrine Cognition to collaborate with University College London to increase insights about golexanolone
STOCKHOLM, SWEDEN - October 19, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company Umecrine Cognition has entered a collaboration with Professor Trevor